Antitrust Lyme Disease Probe Sparks Debate

Law360, New York (May 2, 2008, 12:00 AM EDT) -- Connecticut’s attorney general has settled his unprecedented antitrust investigation into an influential medical association’s Lyme disease treatment guidelines, but antitrust experts say the agreement may still have an interesting side effect: putting medical professionals on notice.

While professional organizations often come under scrutiny from regulators, antitrust actions involving disease treatment guidelines are rare.

Connecticut Attorney General Richard Blumenthal’s antitrust probe of the Infectious Disease Society of America’s process for setting Lyme Disease diagnosis and treatment guidelines has certainly raised questions for doctors, scientists and antitrust specialists....
To view the full article, register now.